Asset Details
Do you wish to reserve the book?
Effect of cirrhosis on prognosis in patients with acute-on-chronic liver failure: a systematic review and meta-analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of cirrhosis on prognosis in patients with acute-on-chronic liver failure: a systematic review and meta-analysis
Do you wish to request the book?
Effect of cirrhosis on prognosis in patients with acute-on-chronic liver failure: a systematic review and meta-analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of cirrhosis on prognosis in patients with acute-on-chronic liver failure: a systematic review and meta-analysis
2025
Overview
Acute-on-chronic liver failure (ACLF) is a prevalent complication among cirrhosis patients, whose high mortality is linked to cirrhosis combined with ACLF. Nevertheless, there is a paucity of systematic reviews. This study aimed to illustrate whether cirrhosis is a prognostic factor for ACLF.
PubMed, Embase, and Cochrane Library were searched for observational studies that explored the connection between cirrhosis and ACLF prognosis from database inception to January 10, 2025. Pooled relative risk (RR) and 95% confidence interval (CI) were utilized for data analyses. Publication bias was estimated using Egger's tests. The protocol was registered in the PROSPERO (CRD42025639557).
This meta-analysis included 17 articles and 8,488 patients of ACLF under different diagnostic criteria. The analyses indicated that cirrhosis did not correlate with 28-day mortality of ACLF patients (RR = 1.08, 95% CI [0.84-1.39],
= 0.550,
= 88.8%) but independently predicted 90-day mortality (RR = 1.33, 95% CI [1.10-1.61],
= 0.004,
= 92.6%). Subgroup analyses of cirrhosis discovered no significant difference in 28-day and 90-day mortality between non-cirrhosis patients and those with compensated cirrhosis (
> 0.05). The 90-day mortality in decompensated cirrhosis patients was markedly higher than that in non-cirrhosis individuals (RR = 1.33, 95% CI [1.14-1.56],
< 0.001,
=64.2%).
Compensated cirrhosis did not correlate with the 28-day mortality of ACLF patients, while it was an independent risk factor for 90-day mortality.
Publisher
PeerJ. Ltd,PeerJ, Inc,PeerJ Inc
